Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2020

View Archived Issues

BMS details discovery and preclinical study of pulmonary fibrosis candidate BMS-986278

Blood substitution therapy expands therapeutic time window for stroke

iBET you I can kill those metastases

Elite controller achieves none-in-a-billion status

Efficacy and mechanism of action of novel DNA gyrase inhibitors against mycobacteria

Preclinical results suggest erectile dysfunction drugs can be repurposed to treat osteoporosis

FDA clears IND for global phase II study of CS-1001 for relapsed or refractory ENKTL

Cyprium reports topline clinical data for CUTX-101 in Menkes disease

Janssen Biotech patents DHODH inhibitors

U.S. researchers disclose new bacterial MenE inhibitiors

Skyhawk Therapeutics identifies small molecule splicing modulators for cancer

FDA expands EUA for Veklury to include hospitalized patients with mild or moderate COVID-19

Canwell Biotech synthesizes new TLR agonists

Taisho Pharmaceutical discloses new 20-HETE synthase inhibitors

Data presented on PF-05221304 and PF-06865571 coadministration in NAFLD patients

IIIM-290 development for treating pancreatic cancer advances into the clinic

TRILOGY 2 study of CaPre in severe hypertriglyceridemia does not meet primary endpoint

Akari details plans to develop nomacopan for COVID-19 pneumonia

Can-Fite's IND for phase II study of piclidenoson to treat COVID-19 cleared by FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...